Casandra
Casandra Test Code QD71252Version 1 (DRAFT)
Performing Lab
Hypoglycemic Panel, Serum/Plasma
Clinical Use
Order TestUse
This panel is used to qualitatively detect the presence of multiple oral hypoglycemic medications—including sulfonylureas and other non-sulfonylurea agents—in serum or plasma, typically to assess compliance or potential surreptitious use of hypoglycemic agents.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
10 targets
ChlorpropamideGlimepirideGlipizideGlyburideNateglinidePioglitazoneRepaglinideRosiglitazone+2 more
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Collection Instructions
Serum collected in a red‑top tube (no gel); promptly centrifuge and separate into a plastic screw‑capped vial.
Causes for Rejection
Received room temperature >48 hours • Polymer gel separation tube (PST) • Serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 28 days |
| Frozen | 2 years |
Related Tests
Other tests from different labs that may be relevant
Hypoglycemia Panel (Sulfonylureas), Serum or Plasma
ARUP Laboratories
Sulfonylurea Analysis, Serum or Plasma
Labcorp
Hypoglycemic Agent Screen, Serum
Mayo Clinic Lab
Glipizide, Serum or Plasma
Labcorp
Glyburide, Serum or Plasma
Labcorp
Glipizide (Glucotrol)
Mayo Clinic Lab
Metformin Quantitative, Serum or Plasma
ARUP Laboratories
Diazoxide Quantitative, Serum or Plasma
ARUP Laboratories